Evidence map›Paper›PMID 31748913›Full record

ReviewCellular and molecular life sciences : CMLS2020

Structural basis of homologous recombination.

Yueru Sun, Thomas J McCorvie, Luke A Yates, Xiaodong Zhang

Open access · hybridAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 157 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. RAD51AP1 is a versatile RAD51 modulator.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Review
  9. SMC6 expression & outcome of breast cancer.The Indian journal of medical research · 2025
    Article
  10. Epigenetic networks coordinate DNA methylation across the genome.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  11. Article
  12. Review
  13. International journal of oncology · 2025
    Review
  14. Article
  15. Review
  16. DNA Damage and Replication Stress Checkpoints.Annual review of biochemistry · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yueru SunSection of Structural Biology, Department of Infectious Diseases, Imperial College, London, SW7 2AZ, UK.
Thomas J McCorvieSection of Structural Biology, Department of Infectious Diseases, Imperial College, London, SW7 2AZ, UK.
Luke A YatesSection of Structural Biology, Department of Infectious Diseases, Imperial College, London, SW7 2AZ, UK.
Xiaodong ZhangSection of Structural Biology, Department of Infectious Diseases, Imperial College, London, SW7 2AZ, UK. xiaodong.zhang@imperial.ac.uk.
Imperial College London · GB

Funding

Medical Research Council MR/J001201/1Medical Research Council MR/N000188/1Wellcome Trust 098412/Z/12/ZWellcome Trust 210658/Z/18/Z
6 · The paper itself

Abstract

Homologous recombination (HR) is a pathway to faithfully repair DNA double-strand breaks (DSBs). At the core of this pathway is a DNA recombinase, which, as a nucleoprotein filament on ssDNA, pairs with homologous DNA as a template to repair the damaged site. In eukaryotes Rad51 is the recombinase capable of carrying out essential steps including strand invasion, homology search on the sister chromatid and strand exchange. Importantly, a tightly regulated process involving many protein factors has evolved to ensure proper localisation of this DNA repair machinery and its correct timing within the cell cycle. Dysregulation of any of the proteins involved can result in unchecked DNA damage, leading to uncontrolled cell division and cancer. Indeed, many are tumour suppressors and are key targets in the development of new cancer therapies. Over the past 40 years, our structural and mechanistic understanding of homologous recombination has steadily increased with notable recent advancements due to the advances in single particle cryo electron microscopy. These have resulted in higher resolution structural models of the signalling proteins ATM (ataxia telangiectasia mutated), and ATR (ataxia telangiectasia and Rad3-related protein), along with various structures of Rad51. However, structural information of the other major players involved, such as BRCA1 (breast cancer type 1 susceptibility protein) and BRCA2 (breast cancer type 2 susceptibility protein), has been limited to crystal structures of isolated domains and low-resolution electron microscopy reconstructions of the full-length proteins. Here we summarise the current structural understanding of homologous recombination, focusing on key proteins in recruitment and signalling events as well as the mediators for the Rad51 recombinase.

Indexed as

DNA DamageProtein Interaction MapsRecombinational DNA RepairAnimalsAtaxia Telangiectasia Mutated ProteinsBRCA1 ProteinBRCA2 ProteinDNAHumansModels, MolecularProtein ConformationRad51 RecombinaseAtaxia Telangiectasia Mutated ProteinsATR protein, humanBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humanDNARad51 RecombinaseCryo electron microscopyDNA damage signalling and repairDouble-strand break repairHomologous recombinationX-ray crystallography

Identifiers

PMID31748913
PMCPMC6957567
OpenAlexW2990667881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.